Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …
…, SA Keshavjee, C Lienhardt… - Clinical infectious …, 2016 - academic.oup.com
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious
Diseases Society of America jointly sponsored the development of this guideline for the …
Diseases Society of America jointly sponsored the development of this guideline for the …
WHO's new end TB strategy
…, D Weil, K Lonnroth, E Jaramillo, C Lienhardt… - The Lancet, 2015 - thelancet.com
On May 19, 2014, the 67th World Health Assembly (WHA) adopted WHO’s “Global strategy
and targets for tuberculosis prevention, care and control after 2015”. 1 This post-2015 global …
and targets for tuberculosis prevention, care and control after 2015”. 1 This post-2015 global …
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
…, S Kik, K Kranzer, C Lienhardt… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …
[HTML][HTML] A four-month gatifloxacin-containing regimen for treating tuberculosis
…, O Lapujade, PL Olliaro, C Lienhardt - … England Journal of …, 2014 - Mass Medical Soc
Background Shortening the course of treatment for tuberculosis would be a major improvement
for case management and disease control. This phase 3 trial assessed the efficacy and …
for case management and disease control. This phase 3 trial assessed the efficacy and …
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis
…, CE Moore, K Knox, SJ Campbell, C Lienhardt… - Nature …, 2007 - nature.com
Toll-like receptors (TLRs) and members of their signaling pathway are important in the
initiation of the innate immune response to a wide variety of pathogens 1 , 2 , 3 . The adaptor …
initiation of the innate immune response to a wide variety of pathogens 1 , 2 , 3 . The adaptor …
Global tuberculosis drug development pipeline: the need and the reality
Drugs for tuberculosis are inadequate to address the many inherent and emerging
challenges of treatment. In the past decade, ten compounds have progressed into the clinical …
challenges of treatment. In the past decade, ten compounds have progressed into the clinical …
Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11. 2
…, PE Fine, PC Hill, M Newport, C Lienhardt… - Nature …, 2010 - nature.com
We combined two tuberculosis genome-wide association studies from Ghana and The Gambia
with subsequent replication in a combined 11,425 individuals. rs4331426, located in a …
with subsequent replication in a combined 11,425 individuals. rs4331426, located in a …
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
…, L González-Angulo, C Lienhardt… - European …, 2017 - Eur Respiratory Soc
Antimicrobial resistance is a major global concern. Tuberculosis (TB) strains resistant to
rifampicin and other TB medicines challenge patient survival and public health. The World …
rifampicin and other TB medicines challenge patient survival and public health. The World …
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis
R Rustomjee, C Lienhardt, T Kanyok… - … of tuberculosis and …, 2008 - ingentaconnect.com
SETTING: Current treatment for pulmonary tuberculosis (TB) might be shortened by the
incorporation of fluoroquinolones (FQs).OBJECTIVES: A Phase II study aimed to assess the …
incorporation of fluoroquinolones (FQs).OBJECTIVES: A Phase II study aimed to assess the …
Scaling up interventions to achieve global tuberculosis control: progress and new developments
…, GB Migliori, AD Harries, P Nunn, C Lienhardt… - The Lancet, 2012 - thelancet.com
Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet
tuberculosis series provided a comprehensive overview of global control efforts and …
tuberculosis series provided a comprehensive overview of global control efforts and …